84 | Proteins (Proteins, Gene)FDA Link
01/2022
-
08/2002 |
44 | Sp Transcription FactorsIBA
10/2021
-
03/2007 |
42 | Pharmaceutical PreparationsIBA
10/2020
-
03/2002 |
36 | LigandsIBA
12/2021
-
06/2002 |
29 | Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2022
-
06/2002 |
27 | Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
06/2022
-
07/2005 |
25 | SurvivinIBA
05/2022
-
03/2007 |
25 | Estrogens (Estrogen)FDA Link
10/2021
-
06/2002 |
24 | Messenger RNA (mRNA)IBA
01/2020
-
08/2002 |
24 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2016
-
02/2004 |
23 | PPAR gammaIBA
06/2010
-
03/2003 |
21 | Estrogen Receptor alphaIBA
06/2010
-
01/2002 |
19 | Antineoplastic Agents (Antineoplastics)IBA
04/2021
-
03/2002 |
18 | Cyclin D1IBA
11/2016
-
03/2003 |
16 | Orphan Nuclear ReceptorsIBA
05/2022
-
03/2010 |
16 | Transcription Factors (Transcription Factor)IBA
10/2021
-
05/2003 |
16 | Hormones (Hormone)IBA
10/2020
-
06/2002 |
16 | Polychlorinated Dibenzodioxins (TCDD)IBA
01/2020
-
06/2002 |
15 | Estrogen ReceptorsIBA
01/2021
-
06/2002 |
15 | Reactive Oxygen Species (Oxygen Radicals)IBA
11/2019
-
08/2010 |
14 | Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2021
-
01/2004 |
13 | 3,3'-diindolylmethane (diindolylmethane)IBA
01/2018
-
04/2006 |
12 | tolfenamic acidIBA
02/2014
-
06/2006 |
11 | indoleIBA
06/2022
-
10/2008 |
9 | TriterpenesIBA
10/2021
-
03/2007 |
9 | Member 1 Group A Nuclear Receptor Subfamily 4IBA
04/2021
-
09/2010 |
9 | methyl 2- cyano- 3,11- dioxo- 18beta- olean- 1,12- dien- 30- oateIBA
01/2020
-
05/2007 |
9 | MicroRNAs (MicroRNA)IBA
04/2015
-
02/2006 |
9 | 1,1- bis(3'- indolyl)- 1- (4- t- butylphenyl)methaneIBA
09/2011
-
09/2004 |
8 | ErbB Receptors (EGF Receptor)IBA
12/2021
-
05/2010 |
8 | 1,1- bis(3'- indolyl)- 1- (4- hydroxyphenyl)methaneIBA
11/2019
-
09/2010 |
8 | Proteasome Endopeptidase Complex (Proteasome)IBA
12/2018
-
10/2002 |
8 | Betulinic AcidIBA
11/2016
-
03/2007 |
8 | rat MIRN27 microRNAIBA
12/2015
-
11/2007 |
7 | PhytochemicalsIBA
04/2021
-
11/2007 |
7 | LuciferasesIBA
01/2020
-
02/2004 |
7 | Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2014
-
06/2006 |
7 | Caveolin 1IBA
05/2010
-
09/2004 |
6 | Proto-Oncogene Proteins c-metIBA
05/2021
-
07/2009 |
6 | Omeprazole (Prilosec)FDA LinkGeneric
07/2020
-
11/2012 |
6 | CurcuminIBA
01/2018
-
07/2008 |
6 | Glutathione (Reduced Glutathione)IBA
08/2017
-
10/2005 |
5 | RNA (Ribonucleic Acid)IBA
01/2019
-
08/2002 |
5 | Metformin (Glucophage)FDA LinkGeneric
01/2018
-
12/2013 |
5 | AntioxidantsIBA
08/2017
-
05/2008 |
4 | Biological ProductsIBA
01/2021
-
03/2007 |
4 | CarcinogensIBA
01/2021
-
03/2004 |
4 | Phosphotransferases (Kinase)IBA
01/2020
-
12/2005 |
4 | CytokinesIBA
01/2020
-
01/2014 |
4 | Glycyrrhetinic Acid (Po 12)IBA
01/2019
-
05/2007 |
4 | Hypoglycemic Agents (Hypoglycemics)IBA
01/2018
-
12/2013 |
4 | AcidsIBA
01/2017
-
11/2007 |
4 | TamoxifenFDA LinkGeneric
01/2012
-
06/2002 |
4 | 6-methyl-1,3,8-trichlorodibenzofuranIBA
01/2012
-
04/2004 |
4 | Estrogen Receptor Modulators (Antiestrogen)IBA
11/2008
-
05/2003 |
3 | ResveratrolIBA
06/2022
-
05/2008 |
3 | FlavonoidsIBA
12/2021
-
01/2018 |
3 | celastrolIBA
10/2021
-
04/2012 |
3 | Tryptophan (L-Tryptophan)FDA Link
10/2020
-
10/2015 |
3 | Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020
-
05/2016 |
3 | 1,1- bis(3'- indolyl)- 1- (4- chlorophenyl)methaneIBA
01/2020
-
12/2008 |
3 | Leflunomide (Arava)FDA LinkGeneric
05/2018
-
11/2012 |
3 | Flutamide (Eulexin)FDA LinkGeneric
05/2018
-
07/2014 |
3 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2018
-
02/2015 |
3 | Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018
-
01/2011 |
3 | indole-3-carbinolIBA
02/2017
-
10/2008 |
3 | tranilastIBA
02/2017
-
07/2014 |
3 | bardoxolone methylIBA
01/2017
-
07/2005 |
3 | Hydroxyl RadicalIBA
01/2017
-
03/2004 |
3 | NF-kappa B (NF-kB)IBA
11/2016
-
08/2002 |
3 | Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2016
-
07/2005 |
3 | Sulindac (Copal)FDA LinkGeneric
12/2015
-
11/2012 |
3 | DioxinsIBA
09/2015
-
06/2003 |